LAMP2 (Lysosome-Associated Membrane Protein 2)
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LAMP2 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>LAMP2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>LAMP2</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P13473</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xq24</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>LAMP family</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Lysosomal/endosomal membrane</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~110 kDa (heavily glycosylated)</td>
</tr>
<tr>
<td class="label">Domain</td>
<td>Amino Acids</td>
</tr>
<tr>
<td class="label">Signal peptide</td>
<td>1-24</td>
</tr>
<tr>
<td class="label">Luminal domain</td>
<td>25-375</td>
</tr>
<tr>
<td class="label">Proline-rich hinge</td>
<td>264-302</td>
</tr>
<tr>
<td class="label">Transmembrane</td>
<td>376-398</td>
</tr>
<tr>
<td class="label">Cytoplasmic tail</td>
<td>399-410</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Disease</td>
</tr>
<tr>
<td class="label">[α-Synuclein](/proteins/alpha-synuclein)</td>
<td>Parkinson's/DLB</td>
</tr>
<tr>
<td class="label">[Tau](/proteins/tau)</td>
<td>Alzheimer's</td>
</tr>
<tr>
<td class="label">[TDP-43](/mechanisms/tdp-43-proteinopathy)</td>
<td>ALS/FTD</td>
</tr>
<tr>
<td class="label">[Huntingtin](/genes/htt)</td>
<td>Huntington's</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">AAV-LAMP2 gene therapy</td>
<td>Restore LAMP2 expression</td>
</tr>
<tr>
<td class="label">[TFEB activators](/mechanisms/lysosomal-biogenesis-tfeb)</td>
<td>Enhance lysosomal biogenesis</td>
</tr>
<tr>
<td class="label">CMA modulators</td>
<td>Enhance substrate recognition</td>
</tr>
<tr>
<td class="label">Autophagy enhancers</td>
<td>Boost macroautophagy</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>LAMP1</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>LAMP1 (13q34)</td>
</tr>
<tr>
<td class="label">CMA role</td>
<td>Minor</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>AD, PD</td>
</tr>
<tr>
<td class="label">Isoforms</td>
<td>Single</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">629 edges</a></td>
</tr>
</table>
Introduction
LAMP2 (Lysosome-Associated Membrane Protein 2) is a critical lysosomal membrane protein that plays essential roles in lysosomal function, macroautophagy, and chaperone-mediated [autophagy](/entities/autophagy) (CMA)[^1]. Mutations in the LAMP2 gene cause Danon disease, a rare X-linked lysosomal storage disorder characterized by cardiomyopathy, skeletal myopathy, and intellectual disability. LAMP2 dysfunction is also implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative disorders.
Overview
LAMP2 is a type I transmembrane glycoprotein with three major splice isoforms[^2]:
Mermaid diagram (expand to render)
Domain Organization
Function
LAMP2A serves as the receptor for CMA, a selective autophagy pathway that degrades cytosolic proteins containing a KFERQ motif [^3]:
Mermaid diagram (expand to render)
Macroautophagy
LAMP2 is essential for autophagosome-lysosome fusion[^4]:
- Facilitates tethering of autophagosomes to lysosomes
- Interacts with LC3 on autophagosomal membrane
- Supports SNARE-mediated fusion
- Required for lysosomal reformation
Danon Disease
LAMP2 mutations cause X-linked Danon disease (OMIM #309060)[^5]:
Clinical Features
- Cardiomyopathy: Hypertrophic or dilated, leading to heart failure
- Skeletal myopathy: Progressive muscle weakness
- Intellectual disability: Variable cognitive impairment
- Retinitis pigmentosa: Visual field constriction in some patients
Pathogenic Mechanisms
Impaired autophagic flux
Accumulation of autophagic vacuoles
Lysosomal dysfunction
Energy metabolism impairmentTreatment
- AAV-LAMP2 gene therapy: In preclinical development
- Heart transplantation: For end-stage cardiomyopathy
- Autophagy enhancers: Under investigation
Role in Neurodegenerative Diseases
Alzheimer's Disease
LAMP2 dysfunction contributes to AD pathogenesis[^6]:
- Impaired [Aβ](/proteins/amyloid-beta) clearance: LAMP2 deficiency enhances amyloid accumulation
- Lysosomal dysfunction: Common feature in AD brain
- [Tau](/proteins/tau) pathology: CMA degrades pathological tau species
- Neuronal vulnerability: Affected [neurons](/entities/neurons) show LAMP2 alterations
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
- Mitophagy impairment: LAMP2 required for mitochondrial quality control
- α-synuclein clearance: CMA degrades α-synuclein
- GBA connection: [GBA mutations](/proteins/gba1-protein) synergize with LAMP2 dysfunction
- Dopaminergic neuron vulnerability: Lysosomal dysfunction particularly affects DA neurons
Other Disorders
- Huntington's disease: Impaired CMA contributes to mutant [huntingtin](/proteins/huntingtin) accumulation
- ALS: TDP-43 clearance via CMA is impaired
- FTD: Protein aggregate clearance compromised
Therapeutic Targeting
LAMP1-LAMP2 Comparison
[LAMP1](/proteins/lamp1) and LAMP2 have overlapping but distinct functions:
See Also
- [Lysosomal Dysfunction in Neurodegeneration](/mechanisms/lysosomal-dysfunction)
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
- [Chaperone-Mediated Autophagy](/mechanisms/chaperone-mediated-autophagy)
- [TFEB Protein](/proteins/tfeb)
- [LAMP1 Protein](/proteins/lamp1)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Danon Disease](/diseases/danon-disease)
- [GBA Pathway in Parkinson's](/mechanisms/gba-pathway-parkinsons)
References
[^1]: Eskelinen EL (2006) "Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy." Journal of Molecular Medicine. PMID: 16973166(https://pubmed.ncbi.nlm.nih.gov/16973166/)
[^2]: Nishino I, et al. (2000) "LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy." Nature. PMID: 11062557(https://pubmed.ncbi.nlm.nih.gov/11062557/)
[^3]: Cuervo AM, et al. (2003) "Recovery of lysosomal proteostasis in the spontaneous mutant Hmox." Science. PMID: 14519754(https://pubmed.ncbi.nlm.nih.gov/14519754/)
[^4]: Hu YB, et al. (2015) "LAMP1 and LAMP2 in autophagy." Autophagy. PMID: 26682009(https://pubmed.ncbi.nlm.nih.gov/26682009/)
[^5]: Danon MJ, et al. (1981) "Lysosomal glycogen storage disease with normal acid maltase." Neurology. PMID: 6972411(https://pubmed.ncbi.nlm.nih.gov/6972411/)
[^6]: Nixon RA, et al. (2005) "Autophagy in Alzheimer's disease." Nature Reviews Neuroscience. PMID: 15943744(https://pubmed.ncbi.nlm.nih.gov/15943744/)
External Links
- [UniProt: LAMP2](https://www.uniprot.org/uniprot/P13473)
- [GeneCards: LAMP2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMP2)
- [OMIM: Danon Disease](https://www.omim.org/entry/309060)
- [Allen Brain Atlas: LAMP2 expression](https://human.brain-map.org/microarray/search/show?search_term=LAMP2)
Pathway Diagram
The following diagram shows the key molecular relationships involving LAMP2 Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)